Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Medtronic received Food and Drug Administration clearance for its new InPen smart insulin pen app that can recommend ...

A Cornerstone in Diabetes ManagementInsulin delivery devices market are innovative medical instruments designed to provide ...

The companion app for the InPen digital insulin pen is designed to connect with the company’s latest Simplera continuous glucose monitor, offering users personalized dosing suggestions based on ...

including a smart insulin pen that tracks doses and a body worn monitor that makes real-time glucose readings for people who make multiple daily injections. Diabetes management is challenging ...

Provided image of Medtronic's Smart MDI system combines its InPen smart insulin pen with continuous glucose monitor to help users calculate insulin doses.

It combines the company’s InPen smart insulin pen with its Simplera continuous glucose monitor (CGM), a disposable, all-in-one device. The MDI system is poised to be the first on the market to ...

The company’s Smart MDI system combines its InPen smart insulin pen with its newest Simplera(TM) CGM – the company’s first disposable, all-in-one CGM that’s half the size of previous ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of its popular obesity and diabetes injections. The ...

The company's Smart MDI system combines its InPen™ smart insulin pen with its newest Simplera™ CGM — the company's first disposable, all-in-one CGM that's half the size of previous Medtronic ...